Skip to main content
Premium Trial:

Request an Annual Quote

UPDATE: Lion Introduces ArrayScout 2.0

NEW YORK, Jan 24 – Lion Bioscience has released ArrayScout 2.0, an updated version of its gene expression data analysis system, and will begin shipping and installing it at customer sites immediately, the company said Wednesday.

This new version, the third commercial release of ArrayScout since Lion rolled out this software in Fall 1999, provides new clustering and visualization tools and an open application programming interface that enables users to integrate ArrayScout with their own analysis tools. These features augment the system’s capabilities for analyzing gene data from Affymetrix GeneChips and spotted arrays, the company said.

The new version also addresses problems with data quality common in microarray analysis, according to Christian Marcazzo, director of product marketing for Lion.

“We’ve done quite a bit of work in quality control and data normalization, Marcazzo said. “Our scientists have a fundamental problem that analysis of data is not very useful when the data is dirty, for example when hair gets on the chip or dust gets on the chip. Decisions need to be made as to whether some part of the chip needs to be thrown away.”

Lion is planning to introduce two other modules, PiScout for molecular interactions and PathScout for biological pathway analysis, in the coming months, Marcazzo said.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.